Colon Capsule for Colonic Polyps

This trial focuses on developing software to detect colonic polyps using capsule images from the CapsoCam® Colon device. The goal is to enhance image analysis for future colonoscopy procedures. Participants must follow specific dietary guidelines, take medication to aid the capsule's movement through the digestive system, and return the capsule after it passes. This trial suits individuals referred for a colonoscopy who have not recently undergone a procedure showing no polyps. As an unphased trial, it offers participants the chance to contribute to innovative research that could improve future colonoscopy experiences.

The trial information does not specify if you need to stop taking your current medications. However, if you use narcotics regularly or have a history of NSAID-related issues, you may not be eligible to participate.

Research shows that the CapsoCam® Colon (CV-3E) is generally easy for patients to handle. Patients swallow this tiny camera capsule to capture images of the colon, aiding doctors in identifying polyps. In past uses of similar technology, most people did not experience significant side effects. Some might feel mild discomfort, such as bloating or cramping, but these effects usually resolve quickly.

Researchers are excited about the CV-3E AI Software because it introduces a new way to detect colonic polyps using the CapsoCam® Colon capsule. Unlike traditional colonoscopies, which are invasive and require sedation, this method involves swallowing a small capsule equipped with a camera, making the process less uncomfortable and more accessible. The AI software assists in analyzing the images captured by the capsule, potentially increasing the accuracy and efficiency of polyp detection. This innovative approach could lead to earlier detection and treatment of colonic polyps, improving outcomes for patients.

Studies have shown that artificial intelligence (AI) technology, such as the CV-3E AI software, effectively identifies growths in the colon called polyps. Research indicates that AI use during colonoscopies helps doctors more easily detect adenomas, polyps that might become cancerous. In this trial, participants will swallow the CapsoCam® Colon (CV-3E), which captures images of the colon. The AI analyzes these images to spot polyps with greater accuracy. Early findings suggest this method could be more reliable than regular screenings alone. Although still in development, initial results demonstrate its potential to improve early detection of colon issues.¹²³⁵⁶